New twist on potential malaria drug target acts by trapping parasites in cells
For immediate release: Thursday, May 13, 2010 Boston, MA -- Harvard School of Public Health (HSPH) researchers and colleagues seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites…
Severity of H1N1 flu in U.S. during current flu season may be less than feared
Burden of Disease May Fall on Young Children and Non-Elderly Adults For immediate release: Monday, December 7, 2009 Boston, MA—A new study from researchers at the UK Medical Research Council and the Harvard School of Public Health (HSPH)…
HSPH-led team discovers protective cellular process in ALS disease in mice, hinting at new therapeutic approach
Boston, MA -- When Harvard School of Public Health (HSPH) scientists disabled a specific protein in mice that were genetically prone to develop ALS (Lou Gehrig's disease), they expected -- based on previous work -- to hasten the…
HSPH investigators help lead H1N1 research and response
[Fall 2009] Catching the flu before it catches the world As a new influenza pandemic this spring set off alarms in the global health community, Harvard School of Public Health scholars helped illuminate the crisis and lead a…
Center for Communicable Disease dynamics to be established at HSPH to model factors involved in infectious disease spread and intervention
For immediate release: Thursday, September 3, 2009 Boston, MA -- A new center that will focus on mathematical modeling of drug resistance, seasonal infectious diseases, and intervention allocation will be established at the Harvard School of Public Health…
Harvard School of Public Health professor Barry R. Bloom named recipient of national award for contributions to understanding immune responses to infectious diseases
For immediate release: September 2, 2009 Boston, MA -- Barry R. Bloom, Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Harvard School of Public Health (HSPH), will receive…
The cost of South Africa's misguided AIDS policies
[ Spring 2009 ] The human cost of South Africa's misguided AIDS policies AIDS activists and researchers argued for years that the negligent HIV/AIDS policies of former South African President Thabo Mbeki were causing a massive, unconscionable loss of human life. Now,…
In a flu pandemic, first using small stockpile of secondary drug could delay resistance to primary stockpiled medication
For immediate release: Thursday, April 30, 2009 Boston, MA -- In a global influenza pandemic, small stockpiles of a secondary flu medication -- if used early in local outbreaks -- could extend the effectiveness of primary drug stockpiles,…
Polio
[Winter 2009] Remembering the late HSPH Nobel Laureate, Thomas Weller As the polio virus swept across the United States in 1948, 32-year-old Thomas Weller was logging long hours in a Harvard Medical School laboratory, working to develop a…
Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
For immediate release: Monday, October 20, 2008 Boston, MA - More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert…